Coya Therapeutics Statistics
NASDAQ: COYAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
2.95-0.03 (-1.01%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Coya Therapeutics by the numbers
Coya Therapeutics has a market capitalization of $69.2 million based on 23.46M shares outstanding. With trailing EPS of $-1.39, Coya Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 28.7% below its 50-day average and 34.9% below its 200-day average.
Average daily trading volume is 149.18K shares, or about $440,093 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
COYA valuation vs. peer median
| Metric | COYA | Peer median | Difference |
|---|---|---|---|
| Market cap | $69.20M | $66.70M | +4% |
| Avg. volume | 149.18K | 308.22K | -52% |
Peer median across 8 companies: ZYBT, MAIA, CING, MNOV, PLYX, PMVP, GOSS, FBIO.
Valuation
- Market cap
- $69.20M
- Price / sales (latest FY)
- 8.71
- EPS (TTM)
- $-1.39
- Shares outstanding
- 23.46M
Price and trading
- Previous close
- 2.98
- Open
- 2.94
- Day range
- 2.90 – 3.11
- 52-week range
- 2.72 – 6.62
- 52-week change
- -50.67%
- Beta
- —
- Volume
- 138.27K
- Average volume
- 149.18K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 10, 2026
Additional statistics
- Market Cap
- 69.20M
- Forward Pe
- -1.46
- Eps
- -1.39
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 6.62
- Week52 Low
- 2.72
- Avg Volume
- 149.18K
- Shares Outstanding
- 23.46M
- Ma50
- 4.14
- Ma200
- 4.53
- Earnings Date
- Nov 10, 2026
- Pct From52w High
- -55.44%
- Pct From52w Low
- 8.46%